# A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

> **NCT00028067** · PHASE3 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 500 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Nelfinavir mesylate

## Key facts

- **NCT ID:** NCT00028067
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-08
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 500 (—)
- **Last updated:** 2011-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028067, "A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00028067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*